Risk Factors for Recurrence after Resection of Hepatitis C Virus-related Hepatocellular Carcinoma

被引:0
|
作者
Shoji Kubo
Kazuhiro Hirohashi
Hiromu Tanaka
Tadashi Tsukamoto
Taichi Shuto
Takashi Ikebe
Takatsugu Yamamoto
Kenichi Wakasa
Shuhei Nishiguchi
Tetsuo Kuroki
Hiroaki Kinoshita
机构
[1] Second Department of Surgery,
[2] Osaka City University Medical School,undefined
[3] 1-4-3 Asahimachi,undefined
[4] Abeno-ku,undefined
[5] Osaka 545-8585,undefined
[6] Japan,undefined
[7] Second Department of Pathology,undefined
[8] Osaka City University Medical School,undefined
[9] 1-4-3 Asahimachi,undefined
[10] Abeno-ku,undefined
[11] Osaka 545-8585,undefined
[12] Japan,undefined
[13] Department of Pathology,undefined
[14] Osaka City University Hospital,undefined
[15] 1-5-3 Asahimachi,undefined
[16] Abeno-ku,undefined
[17] Osaka 545-8586,undefined
[18] Japan,undefined
[19] Third Department of Internal Medicine,undefined
[20] Osaka City University Medical School,undefined
[21] 1-4-3 Asahimachi,undefined
[22] Abeno-ku,undefined
[23] Osaka 545-8585,undefined
[24] Japan,undefined
来源
World Journal of Surgery | 2000年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although there have been many studies of the risk factors for recurrence after resection of hepatocellular carcinoma (HCC), the subjects were patients with various viral status in the previous studies, and hepatitis C viremia has not been evaluated. We investigated risk factors, including hepatic C viremia and histologic findings of noncancerous hepatic tissue, for recurrence after resection of hepatitis C virus (HCV)-related HCC. A total of 223 patients who underwent liver resection for HCV-related HCC were studied. HCV viremia, laboratory data, degree of HCC malignancy, histologic findings in noncancerous hepatic tissue, preoperative interferon therapy, and operative methods were evaluated for recurrence risk by univariate and multivariate analyses. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin, and the proportion of patients with a high histologic activity score (mild to severe active hepatitis) were significantly higher in patients with HCV viremia than in those without viremia. Serum albumin was significantly lower in patients with HCV viremia. By univariate analysis, older age (> 65 years old), HCV viremia, elevated AST (> 40 IU/L) and ALT (> 45 IU/L), large tumors (> 40 mm), multiple HCCs, moderately or poorly differentiated HCC, portal invasion, mild to severe active hepatitis, and lack of preoperative interferon therapy were risk factors for recurrence. Multivariate analysis showed that older age, HCV viremia, high AST, multiple HCCs, and portal invasion were independent risk factors. For HCV-related HCCs, not only the degree of maliganacy of the HCC but also HCV viremia and active hepatitis are risk factors for recurrence.
引用
收藏
页码:1559 / 1565
页数:6
相关论文
共 50 条
  • [21] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence
    Yeh, Yi-Chun
    Chen, Pei-Jer
    Lai, Mei-Shu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 765 - 766
  • [22] Independent risk factors for disease recurrence after surgery in patients with hepatitis B virus-related hepatocellular carcinoma ≤3 cm in diameter
    He, Ling-Ling
    Liu, Xiao-Li
    Zhang, Shuan
    Li, Meng-Ge
    Wang, Xian-Bo
    Jiang, Yu-Yong
    Yang, Zhi-Yun
    GASTROENTEROLOGY REPORT, 2019, 7 (04): : 250 - 257
  • [23] Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis
    Chiba, T
    Matsuzaki, Y
    Abei, M
    Shoda, J
    Aikawa, T
    Tanaka, N
    Osuga, T
    JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) : 552 - 558
  • [24] Outcome after resection of hepatitis C virus-related hepatocellular carcinoma improved by postoperative interferon therapy.
    Nishiguchi, S
    Kubo, S
    Hirohashi, K
    Shiomi, S
    Tamori, A
    Oka, H
    Yamazaki, O
    Igawa, S
    Kinoshita, H
    HEPATOLOGY, 2001, 34 (04) : 177A - 177A
  • [25] Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection
    Huo, TI
    Wu, JC
    Lui, WY
    Lee, PC
    Huang, YH
    Chau, GY
    Tsay, SH
    Chang, FY
    Lee, SD
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (11) : 1203 - 1208
  • [26] Circulating exosome DANCR correlated to the recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Wang, Shu-Chi
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Yu, Ming-Lung
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis
    Pecic, V.
    Stankovic-Djordjevic, D.
    Nestorovic, M.
    Radojkovic, M.
    Marjanovic, H.
    Ilic, B.
    Milojkovic, M.
    JOURNAL OF BUON, 2011, 16 (02): : 277 - 281
  • [28] Surgical approach for hepatitis C virus-related hepatocellular carcinoma
    Junichi Shindoh
    Masaji Hashimoto
    Goro Watanabe
    World Journal of Hepatology, 2015, (01) : 70 - 77
  • [29] Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection: A multicenter study
    Qi, Weili
    Shen, Junyi
    Dai, Junlong
    Wu, Youwei
    Zhang, Yu
    Leng, Shusheng
    Gao, Fengwei
    Ran, Shun
    Peng, Wei
    Zhang, Xiaoyun
    Wen, Tianfu
    Li, Chuan
    CANCER MEDICINE, 2021, 10 (23): : 8421 - 8431
  • [30] Antiviral Therapy Decreases Recurrence of Hepatitis B Virus-related Hepatocellular Carcinoma after Curative Resection: A Meta-analysis
    Yanming Zhou
    Zhansai Zhang
    Yanfang Zhao
    Lupeng Wu
    Bin Li
    World Journal of Surgery, 2014, 38 : 2395 - 2402